- HOME >
- For Researchers >
- Product Search >
- Search Result >
- #18163 Anti-Human FHIT (F130) Rabbit IgG Affinity Purify
Product Search
    #18163 Anti-Human FHIT (F130) Rabbit IgG Affinity Purify
- Intended Use:
- Research reagents
- Application:
- WB, IHC
- Package Size1:
- 100 μg
- Package Size2:
- 2x5 μg
- Note on Application Abbreviations
- WB:Western Blotting
- IHC:Immunohistochemistry
※ The product indicated as "Research reagents" in the column Intended Use cannot be used 
   for diagnostic nor any medical purpose.
※ The datasheet listed on this page is sample only. Please refer to the datasheet
   enclosed in the product purchased before use.
Product Overview
Product Overview
| Product Code | 18163 | 
|---|---|
| Product Name | Anti-Human FHIT (F130) Rabbit IgG Affinity Purify | 
| Intended Use | Research reagents | 
| Application | WB, IHC | 
| Species | Human | 
| Immunizing antigen | Synthetic peptide of the C terminal part of Human FHIT | 
| Purification Method | Purified with antigen peptide | 
| Specificity | The specific was confirmed against various human cell lines and peripheral blood lymphocyte by WB, and against various human normal tissue by IHC. | 
| Package Form | Lyophilized product from 1 % BSA in PBS containing 0.05% NaN3 | 
| Storage Condition | 2 - 8℃ | 
| Poisonous and Deleterious Substances | Applicable | 
| Cartagena | Not Applicable | 
| Package Size 1 | 100 μg | 
| Package Size 2 | 2x5 μg | 
| Remarks1 | The commercial use of products without our permission is prohibited. Please make sure to contact us and obtain permission. | 
Product Description
Product Description
A candidate tumor suppressor gene, FHIT, was indicated at chromosome 3p14.2 spanning the FRA3B common fragile site. Abnormalities in structure and expression of the FHIT gene have been detected in a considerable fraction of lung tumors of small and non-small cell types. There are several reports on the correlations between abnormalities of the FHIT gene and clinicopathological features in lung cancer.

















 
		 
		 
		 
		 
		
 
	 
 
				
								 
				
								 
				
								 
				
								 
				
								 
				
								 
				
								 
				
								 
				
								 
				
								